INTEGRAL AD SCIENCE HOLDING CORP. Free cash flow
- Free cash flow · 12 months (USD): Value $176.31M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2025-09-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2025-09-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2025-09-30..
- Free cash flow margin · 12 months: Value 29.85%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2025-09-30..
Free cash flow
Overview →Financial period ending 2025-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $176.31M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2025-09-30. $177.37M − $1.05M ≈ $176.31M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2025-09-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2025-09-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 29.85% | (Operating cash flow − capital spending) / revenue. Period ending 2025-09-30. $176.31M ÷ $590.67M × 100 ≈ 29.85% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2025-09-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $177.37M | Cash generated by operating activities. Period ending 2025-09-30. |
| Operating cash flow / net income · 12 months | 3.80× | Operating cash flow / net income. Period ending 2025-09-30. $177.37M ÷ $46.72M ≈ 3.80× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 177.37M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 1.05M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 176.31M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 590.67M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 46.72M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $176.31M | (m) | $177.37M | $1.05M | (m) | $590.67M | (m) | $46.72M | (m) | (m) | 29.85% | 3.80× |
| 2025-06-30 | $150.69M | (m) | $151.86M | $1.18M | (m) | $569.84M | (m) | $55.76M | (m) | (m) | 26.44% | 2.72× |
| 2025-03-31 | $121.35M | (m) | $122.56M | $1.21M | (m) | $549.64M | (m) | $47.04M | (m) | (m) | 22.08% | 2.61× |
| 2024-12-31 | $116.11M | (m) | $117.90M | $1.78M | (m) | $530.10M | (m) | $37.80M | (m) | (m) | 21.90% | 3.12× |
| 2024-09-30 | $106.14M | (m) | $107.75M | $1.61M | (m) | $511.36M | (m) | $32.69M | (m) | (m) | 20.76% | 3.30× |
| 2024-06-30 | $102.87M | (m) | $104.36M | $1.49M | (m) | $498.16M | (m) | $2.85M | (m) | (m) | 20.65% | 36.62× |
| 2024-03-31 | $105.72M | (m) | $107.54M | $1.82M | (m) | $482.81M | (m) | $2.84M | (m) | (m) | 21.90% | 37.90× |
| 2023-12-31 | $129.65M | (m) | $131.62M | $1.98M | (m) | $474.37M | (m) | $7.24M | (m) | (m) | 27.33% | 18.18× |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $70.45M | (m) | $72.47M | $2.02M | (m) | $408.35M | (m) | $15.37M | (m) | (m) | 17.25% | 4.71× |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $62.64M | (m) | $63.59M | $955.00K | (m) | $323.51M | (m) | $-52.44M | (m) | (m) | 19.36% | -1.21× |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $33.30M | (m) | $33.94M | $638.00K | (m) | $240.63M | (m) | $-32.37M | (m) | (m) | 13.84% | -1.05× |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-2.91M | (m) | $-1.85M | $1.06M | (m) | $213.49M | (m) | $-51.35M | (m) | (m) | -1.36% | 0.04× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.